Abstract
Naltrexone was first registered in the US in 19841 and today is available in many countries as a treatment for both heroin and alcohol dependence. This chapter reviews the safety, efficacy, and effectiveness of naltrexone as a maintenance treatment for opioid dependence. The safety and efficacy of naltrexone as a withdrawal intervention for heroin detoxification was discussed in Chapter 3.
| Original language | English |
|---|---|
| Title of host publication | Pharmacotherapies for the Treatment of Opioid Dependence : Efficacy, Cost-effectiveness, and Implementation Guidelines |
| Editors | Richard P. Mattick, Robert Ali, Nicholas Lintzeris |
| Place of Publication | U.K. |
| Publisher | InformaHealthcare |
| Pages | 252-281 |
| Number of pages | 30 |
| ISBN (Electronic) | 9780203414088 |
| ISBN (Print) | 9781841844008 |
| Publication status | Published - 2009 |